Your browser does not fully support modern features. Please upgrade for a smoother experience.
Submitted Successfully!
Thank you for your contribution! Create more entries and keep sharing your academic knowledge with our community.
Version Summary Created by Modification Content Size Created at Operation
1 Yu Peng -- 175 2026-11-15 16:32:59 |
2 delete taxonomy path Yu Peng -13 word(s) 162 2026-11-15 16:35:05 | |
3 format correct Catherine Yang Meta information modification 162 2026-11-16 03:59:12 |

Video Upload Options

We provide professional Academic Video Service to translate complex research into visually appealing presentations. Would you like to try it?
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Peng, Y. Tyrosine Kinase Inhibitor. Encyclopedia. Available online: https://encyclopedia.pub/entry/62266 (accessed on 22 November 2026).
Peng Y. Tyrosine Kinase Inhibitor. Encyclopedia. Available at: https://encyclopedia.pub/entry/62266. Accessed November 22, 2026.
Peng, Yu. "Tyrosine Kinase Inhibitor" Encyclopedia, https://encyclopedia.pub/entry/62266 (accessed November 22, 2026).
Peng, Y. (2026, November 15). Tyrosine Kinase Inhibitor. In Encyclopedia. https://encyclopedia.pub/entry/62266
Peng, Yu. "Tyrosine Kinase Inhibitor." Encyclopedia. Web. 15 November, 2026.

Tyrosine Kinase Inhibitor

Edit

A tyrosine kinase inhibitor is a compound that suppresses the transfer of phosphate from ATP to tyrosine residues in protein substrates by a tyrosine kinase [1]. Targets include membrane-associated receptor kinases and intracellular nonreceptor kinases involved in cellular signaling. Many inhibitors occupy the ATP-binding region, whereas others bind an allosteric site and stabilize a kinase conformation with reduced catalytic activity [1][2]. Binding can be reversible or involve covalent modification of an appropriately positioned amino acid residue [2]. Individual compounds differ in their recognition of kinase conformations and neighboring binding pockets, producing different selectivity profiles across related enzymes [1][2]. Gefitinib inhibits the epidermal growth factor receptor kinase, with particular receptor mutations associated with increased cellular sensitivity [3]. Conversely, changes in the inhibitor-binding region or amplification of the kinase gene can restore signaling despite drug exposure, as demonstrated for BCR–ABL and imatinib [4]. Reduced tyrosine phosphorylation therefore reflects both inhibitor–kinase binding and the molecular state of the targeted signaling system [1][4].

tyrosine phosphorylation ATP-binding site kinase selectivity allosteric inhibition
Help expand this entry Share your expertise by adding detailed content and references to improve this entry.
Add content

References

  1. Jianming Zhang; Priscilla L. Yang; Nathanael S. Gray; Targeting cancer with small molecule kinase inhibitors. Nat. Rev. Cancer 2009, 9, 28-39. [CrossRef]
  2. Joachim Rudolph; Klaus P. Hoeflich; Arvin C. Dar; Contemporary design of small-molecule kinase modulators: orthosteric, allosteric and induced-proximity strategies. Nat. Rev. Drug Discov. 2026, 25, 595-618. [CrossRef]
  3. J. Guillermo Paez; Pasi A. JänNe; Jeffrey C. Lee; Sean Tracy; Heidi Greulich; Stacey Gabriel; Paula Herman; Frederic J. Kaye; Neal Lindeman; Titus J. Boggon; Katsuhiko Naoki; Hidefumi Sasaki; Yoshitaka Fujii; Michael J. Eck; William R. Sellers; Bruce E. Johnson; Matthew Meyerson; EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy. Science 2004, 304, 1497-1500. [CrossRef]
  4. Mercedes E. Gorre; Mansoor Mohammed; Katharine Ellwood; Nicholas Hsu; Ron Paquette; P. Nagesh Rao; Charles L. Sawyers; Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification. Science 2001, 293, 876-880. [CrossRef]
More
Upload a video for this entry
Information
Subjects: Cancer Therapeutics and Mechanisms
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register : Yu Peng
View Times: 6
Revisions: 3 times (View History)
Update Date: 16 Nov 2026
Notice
You are not a member of the advisory board for this topic. If you want to update advisory board member profile, please contact office@encyclopedia.pub.
OK
Confirm
Only members of the Encyclopedia advisory board for this topic are allowed to note entries. Would you like to become an advisory board member of the Encyclopedia?
Yes
No
${ textCharacter }/${ maxCharacter }
Submit
Cancel
There is no comment~
${ textCharacter }/${ maxCharacter }
Submit
Cancel
${ selectedItem.replyTextCharacter }/${ selectedItem.replyMaxCharacter }
Submit
Cancel
Confirm
Are you sure to Delete?
Yes No
Write an Entry